E
Endpoint Health
Biotech & Life Sciences · Palo Alto, United States · Founded 2018
Delivering new precision therapies to patients MoreLess
Endpoint Health is a pioneering company in the field of precision medicine, focusing on critical illnesses such as sepsis and acute respiratory distress syndrome (ARDS). The company operates in the healthcare sector, specifically targeting patients with severe and life-threatening conditions. Endpoint Health's business model revolves around creating a precision medicine ecosystem that aims to understand patient biology better, how it impacts treatment responses, and to develop new targeted therapies. The company serves hospitals, healthcare providers, and clinical researchers who are in need of advanced, personalized treatment options for their patients. Endpoint Health generates revenue through the development and validation of these targeted therapies, which are then sold to healthcare institutions and providers. The company is committed to ensuring that every critical therapy needed for each patient is available and personalized, thereby improving patient outcomes and reducing hospital deaths.
Keywords: precision medicine, critical illnesses, sepsis, ARDS, targeted therapies, patient biology, healthcare, personalized treatment, clinical research, hospital deaths.
Company overview
Endpoint Health company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- Palo Alto, United States
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 60.3
Valuation & funding
Endpoint Health funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Jun 2022 | $26M | — | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Jun 2022 | $26M | $104M | Wireframe Ventures · Alix Ventures · Boom Capital · AME Cloud Ventures | ↗ |
| SERIES AEquity / VC | Feb 2022 | $0 | — | GRIDS Capital | — |
| EARLY VCEquity / VC | Jul 2020 | $12M | $48M | Mayfield | — |
| SEED✓Equity / VC | Sep 2019 | $125K | $500K | Y Combinator | — |
| OtherOther financing | Mar 2019 | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 5 |
| 2025 | 10 |
| 2024 | 16 |
| 2023 | 33 |
| 2022 | 35 |
| 2021 | 20 |
Growth signals
Endpoint Health team growth
Endpoint Health's team declined 30% over the past year.
Comparisons
Endpoint Health compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Endpoint Health's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Endpoint Health has talent and traffic
team presence
In the news
Latest news about Endpoint Health
Recent press, funding announcements, and product moves mentioning Endpoint Health — open to read from the original sources.
Market sentiment
What the market is saying about Endpoint Health
An AI-synthesized read of the highest-engagement posts about Endpoint Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Endpoint Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.